Remove topic opinion
article thumbnail

Vitiligo treatment gets positive CHMP opinion

European Pharmaceutical Review

The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ruxolitinib cream (Opzelura ) for non-segmental vitiligo with facial involvement in people over 12 years old. News : @EMA_News has issued a positive opinion for an Incyte-discovered therapy for patients with #vitiligo.

article thumbnail

The Promise of Generative AI in Mitigating Bias in Continuing Medical Education

PM360

Once grants are awarded, it becomes the responsibility of education producers to create fair and balanced learning activities with perspectives from a spectrum of published evidence around the topic. They must also look at literature that refutes, or on the other hand, backs up whatever topic is being focused on.

Education 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 Trends for online health seekers

World of DTC Marketing

My research points were Google, Twitter, and various websites that provide metrics on a variety of topics. In my opinion, this is due to pharma being sold on programmatic and the lack of investment in creative. I’ve spent the last three months gathering information on how online health seekers are using the Internet.

Media 287
article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

I’ve seen posts on everything from opinions on detergents to the best and more inexpensive ice cream. Monitor social media and identify possible topics for new content. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different.

Marketing 252
article thumbnail

HOW TO MAXIMIZE THE IMPACT OF PEER INFLUENCE: Top 3 Tips for Content Creation and Delivery

PM360

With the majority of HCPs spending thirty minutes or less per workday engaging with medical news or educational content, the influence of peers and key opinion leaders (KOLs) has become increasingly powerful. Think: KOL videos that take less than 5 minutes to watch, or a podcast series with short episodes breaking down one complicated topic.

article thumbnail

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi approval

Pharmaceutical Technology

The regulator’s positive opinion was based on the data obtained from the pivotal Phase III TRANSFORM trial. The final decision from the European Commission (EC) is expected within around two months of receipt of the CHMP opinion, and will be applicable to all EU member states, Liechtenstein, Norway and Iceland.

article thumbnail

Hearing from HCP Influencers

PM360

Are you a Key Opinion Leader/Digital Opinion Leader for pharma? What’s an important topic to you that you post about? Are you a Key Opinion Leader/Digital Opinion Leader for pharma? What’s an important topic to you that you post about? Are you a Key Opinion Leader/Digital Opinion Leader for pharma?

Media 52